Notice of AGM & Posting of Annual Report&Accounts

RNS Number : 5582Q

Venn Life Sciences Holdings PLC

06 June 2018

 

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Company")

Notice of AGM and Posting of Annual Report and Accounts

Venn Life Sciences (AIM: VENN), an Integrated Drug Development Partner offering a combination of drug development expertise and clinical trial design and management to pharmaceutical, biotechnology and medical device clients, announces that the Annual Report and Accounts for the year ended 31 December 2017 have been posted to shareholders, together with Notice of the Annual General Meeting and a Form of Proxy.

The Annual General Meeting is to be held on Wednesday 27 June 2018 at 12 noon at the Heathrow Marriot, Bath Rd, Harlington, Hayes, UB3 5AN.

The Annual Report and Accounts and the Notice of Annual General Meeting will be on the website at www.vennlifesciences.com/investors 

Enquiries:

Venn Life Sciences Holdings Plc		Tel: [phone]
Allan Wood, Non-Executive Chairman
Tony Richardson, Chief Executive Officer
Cenkos (Nominated Advisor and Co-Broker)		Tel: [phone]
Mark Connelly/Steve Cox (Corporate Finance)
Davy (ESM Adviser and Co-Broker)
Fergal Meegan / Matthew de Vere White (Corporate Finance)			Tel: [phone]
Hybridan (Co-Broker)
Claire Louise Noyce		Tel: [phone]
Walbrook PR Ltd	Tel: [phone]
Paul McManus/ Anna Dunphy

 

END

 

 

ACSKMGGVKVMGRZM